Form 8-K Medtronic plc For: Feb 21

Go back to Form 8-K Medtronic plc For: Feb 21

Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results

February 22, 2017 7:52 AM EST

Wedbush Securities analyst Tao Levy reiterates Neutral rating and $85 price target on Medtronic Plc (NYSE: MDT), suggesting solid results demonstrate recovery from last quarters disruptions, as the company reported fiscal 2017 third quarter revenues above consensus estimates.

Levy comments, "Medtronics broad product portfolio allows the company to... More